Greffrey S. Gilmartin

Chief Development Officer, Proteostasis Therapeutics (United States).

Companies

Proteostasis Therapeutics (United States)Chief Development Officer Oct 27, 2016 to Mar 4, 2020¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARProteostasis Therapeutics (United States), Chief Development Officer